January 2015 Formulary Drug Removals Below is a list of medicines by drug class that have been removed from your plan's formulary. This list is effective January 1, 2015. If you continue using one of the drugs listed below and identified as a Formulary Drug Removal after this date, you may be required to pay the full cost. If you are currently using one of the formulary drug removals, ask your doctor to choose one of the generic or brand formulary consideration options listed below.
Origene.compLenti Destination Vectors
Table of Contents
Package Contents and Related Products
The following components are included:
• One (1) vial containing the cDNA clone as 10 μg lyophilized plasmid DNA*. Reconstitute the DNA in 100 μl of dH20; concentration is 100ng/μl. • 100 picomoles of forward (V2) and reverse (LR50) DNA vector sequencing primers; dried onto the bottom of screw cap tubes. Reconstitute the primer in 10 μl of H2O; concentration is 10 μM. • Certificate of Analysis • Application Guide * OriGeneplasmids are purified using ion-exchange columns for high-yield, low endotoxin preparations (PowerPrep® HP Midiprep Kit www.origene.com/other/Plasmid_Purification.) The cDNA clone is shipped at room temperature, but should be kept at -20°C for long-term storage. If properly stored, clones are guaranteed to be stable for 12 months. Related Optional Reagents
Restriction enzymes and buffers
ASIS I, MluI and RsrII from Fermentas Nuclease free water T4 DNA ligase and buffer Competent E. coli cells (OriGene CC100001) LB agar plates with 50-100 μg/ml Chloramphenicol. LB broth (10 g/L Tryptone, 5 g/L Yeast Extract, 10 g/L NaCl. Adjust pH to 7.0 with 1 N NaOH) DNA purification reagents Related OriGene Products
Lenti-packaging kit TrueClone™ FL cDNA clones HuSH™ shRNA Plasmids Proteins from HEK293 Transfection Reagents Anti-DDK Antibody Anti-fluorescence protein
Notice to purchaser
This product is for research use only. Use in and/or for diagnostics and therapeutics is strictly prohibited. By opening
and using the product, the purchaser agrees to the following: The plasmids may not be distributed, resold,modified for
resale or used to manufacture commercial products without prior written approval from OriGene Technologies, Inc. If
you do not agree to the above conditions, please return the UNOPENED product to OriGene Technologies, Inc.
within ten (10) days of receipt for a full refund.
Eight pLenti vectors are offered by OriGene. Please see the details of the pLenti vectors
at:. One is tagged with
C-terminal MYC/DDK tag (Cat# PS100064) for easy antibody detection and purification.
OriGene recommends 4C5-AntiDDK high affinity mAb (Cat #TA50011) for this work.
The other form is tagged with either GFP or RFP which can be visualized under a
fluorescence microscope and also be detected by Western blotting with anti-GFP or
anti-RFP specific antibody (see details at
The fusion protein is under a CMV promoter for strong constitutive expression or EF1
promoter. The ORF insert can also be easily shuttled into over 70 destination vectors to
create different tagging options via a simple "cut-and-ligate" mechanism/ OriGene offers
the RapidShuttling Kits specifically for this use (origene.com/rapid-shuttling-kit). SV40
ori allows for replication in mammalian cells, the chloramphenicol resistant gene confers
the selection of the plasmid in E. coli. Both 5' and 3' truncated LTR can be used for viral
RNA transcription and packaging of viral particles.
Multiple cloning site of pLenti-C-Myc-DDK Multiple cloning site of pLenti-C-mGFP Experimental Protocols
Protocol for Viral Packaging
OriGene's pLenti-C-Myc-DDK and pLenti-C-mGFP are both the 3rd generation of
lentiviral vectors. For the commercial packaging vectors, we recommend OriGene's
Lenti-vpak packaging kit, cat#,TR30022,
Day 1. Plate 2.5 x 106 of 293T cells on a 10cm dish and incubate at 37oC overnight.
Day 2. Transfection, 1) In a labeled ependorf tube (vial 1), mix the following DNA with 500ul Opti-MEM a. 5 ug of pLenti-shRNA construct or 5 ug of pLenti-ORF expression construct b. 6 ug of packaging plasmids 2) In a separate tube (vial 2), mix 44ul of MegaTran transfection reagent with 500ul 3) Transfer the DNA solution from vial 1 into vial 2 containing MegaTran. Vortex it and incubate 15-30 min at room temperature. 4) Add the mixture of DNA and MegaTran directly to the 10cm dish of 293T cells. Day 3. After 12-18 hrs incubation, change the culture medium. Day 4. Harvest the first batch of viral supernatant from the culture and store it at 4oC. Add fresh culture medium to the cell culture. Day 5. Harvest the second batch of viral supernatant then combine it with the first batch. Spin 3000rpm/min and filter through a 0.45 micron filter to remove cellular debris. The viral titer at this step is usually 106-107 TU/ml**. The viral supernatant is now ready for the majority of transduction applications. If necessary, further concentration can be applied. ** Large ORF inserts will decrease the viral titer. Protocol for Transduction
1. Day 1, plate target cells in three 10 cm plates at a density that will produce approximately 60% confluency in 24 hours. Note: other size formats can also be used depending on the nature of your experiment. Adjust the reagent amount accordingly. 2. Day 2, Remove the growth media from the plates prepared the day before. To plate 1, add 4.5 mL of fresh growth medium and 0.5 mL of Lentiviral particles; To plate 2, add 4.0 mL of growth medium and 1 mL of Lentiviral particles; To plate 3, add 2.5 mL of growth medium and 2.5 mL of Lentiviral particles (for a low titer viral preparation, the amount of virus added can be increased to 5 mL). Mix the solution by gentle swirling. 4. Incubate the cells at 37 oC with 5% CO2 for 4 hours. Remove the transduction medium and add 10 mL of fresh growth medium. Incubate the cells for three more days. The transduced cells are ready for downstream analyses such as RNA and protein detection. Protocol for Tittering Lenti-viral Particles
This protocol is based on the GFP or Myc-DDK tag fusion protein expression to
determine the transduction unit (TU/ml) of lenti-viral particles in HEK293T cells.
Day 1.Seed HEK293T 1 - 4 x 104 cells/ well in a 96-well plate.
Day 2. Carry out transduction according to the transduction protocol with series dilutions
of viral particles. The viral particles should be diluted to 1:100, 1:1000, 1:104, and 1:105
in 500ul final volume in culture medium. 100ul of the viral particles mixture should be
added to each well with at least three replicates.
Day 6.Determine the titer of lenti-viral particles.
Perform immo-fluorescent staining with DDK antibody (4C5,
) if pLenti-c-Myc-DDK used.
Count the fluorescent positive or GFP positive cells using fluorescent microscopy.
Select the dilution which gives around 50 to 200 positive cells/well. Count the triplicates
and average the number of positive cells.
Estimate the viral titer using the following formulation.
Viral titer (TU/ml) = number of positive cells x10x dilution.
Frequently Asked Questions
Is there any safety issue with this pLenti vector?
Answer: The pLenti vector is a third generation lentiviral vector and it is the safest lenti-
viral vector because both LTRs are truncated. Please contact the biosafety office at
your institution prior to use of the pLenti vector for permission and for further institution-
specific instructions. BL2/(+) conditions should be used at all times when handling
lentivirus. All decontamination steps should be performed using 70% ethanol/1% SDS.
Gloves should be worn at all times when handling lentiviral preparations, transfected
cells or the combined transfection reagent and lentiviral DNA.
What is unique about the 3rd generation of Lentiviral vectors?
Answer: The 3rd generation lentiviral vectors are safer than the 2nd generation vectors.
The 3rd generation packaging systems express gag and pol from one packaging vector
and rev from another. The 3rd generation packaging systems DO NOT express tat
(Trans-Activator of Transcription).
What cell line should be used in order to produce lentivirus?
Answer: HEK293T cells are commonly used to produce lentivirus. The HEK293T cell
line for producing lentiviral particles can be obtained from ATCC (www.atcc.org).
How do I propagate the pLenti vector in E. coli?
Answer: The lenti-viral vector can be amplified using high-efficiency, competent E. coli
cells (≥ 1×108 CFU/μg DNA) following the manufacturer's transformation protocol. Plate
the transformants on LB-agar plates supplemented with 34 μg/ml chloramphenicol.
Can I use the pLenti vector for stable selection in mammalian cells?
Answer: Only a subset of the pLenti vectors have mammalian selectable markers and
those without a mammalian selection marker can not be used for mammalian selection.
You can make stable cell lines using the pLenti-C-Myc-DDK-IRES-Puro vector. You
might also be able to get stable cells by GFP sorting using the pLenti-C-Myc-DDK-
How do I clone an insert into the pLenti vector?
Answer: The multiple-cloning site of the pLenti vector is compatible with OriGene's
PrecisionShuttling system, a simple cut-and-ligation process. Please refer to the
corresponding protocols in the TrueORF application guide.
What is the size limit for the ORF that is to be cloned into the pLenti vector?
Answer: In general, lentiviral vectors have the capacity to accommodate an insert of 9
kb. However, ORFs larger than 4kb will dramatically decrease the packaging efficiency.
Can pLenti vectors be used in direct transfections as opposed to making virus?
Answer: OriGene's pLenti vectors can also be used in transient transfections to achieve
expression of the transgene. This usually involves lower levels of protein production due
to diminished transfection efficiency.
What is the difference between a lentivirus and a retrovirus?
Answer: Lenti viruses are a subtype of retrovirus. The main difference between
lentiviruses and standard retroviruses from an experimental standpoint is lentiviruses
are capable of infecting both non-dividing and actively dividing cell types whereas
standard retroviruses can only infect mitotically active cell types. Both lentiviruses and
standard retroviruses use the gag, pol, and env genes for packaging. However, the
isoforms of these proteins used by retroviruses and lentiviruses are different and
lentiviral vectors may not be efficiently packaged by each other's packaging systems.
Can I use a second generation packaging system with the pLenti vectors?
Answer: Yes, a second generation packaging system should work with OriGene's third
generation pLenti vectors although we have not explicitly tested this. You can use
OriGene's third generation packaging kit, cat# TR30002 for pLenti vectors.
DeMISTifying Deidentification of PHI in Free-formatted Text March 2016 Approved for Public Release; Distribution Unlimited. Case Number 16-0670 © 2016 The MITRE Corporation. All rights reserved. Introduction Tool Rationale MITRE Identification Scrubber Toolkit (MIST) Use Case 1 – Deidentification Hiding in Plain Sight Use Case 2 – Identification of PHI in e-mail Privacy Risk Identification and Management